Related Experiment Video
Updated: Dec 12, 2025
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
923
Platelets and Defective N-Glycosylation
Elmina Mammadova-Bach1, Jaak Jaeken2, Thomas Gudermann3
1Division of Nephrology, Department of Medicine IV, Hospital of the Ludwig Maximilian University of Munich, 80336 Munich, Germany.
International Journal of Molecular Sciences
|August 13, 2020
Summary
Congenital disorders of glycosylation (CDG) involve N-glycan defects affecting protein function. This review examines N-glycosylation in platelets, highlighting their role in CDG pathogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- N-glycans are crucial for protein folding, stability, and preventing aggregation in the endoplasmic reticulum.
- Congenital disorders of glycosylation (CDG) arise from defects in glycan synthesis, processing, or attachment, impacting protein and lipid functions.
- While CDG are known to affect clotting factors, N-glycosylation of platelet proteins in CDG remains understudied.
Purpose of the Study:
- To review the normal and deficient N-glycosylation of platelet-derived molecules.
- To discuss the involvement of platelets in the pathophysiology of congenital disorders of N-glycosylation.
Main Methods:
- Literature review focusing on N-glycosylation, CDG, and platelet biology.
- Analysis of existing studies on platelet function and glycosylation defects in CDG patients.
Main Results:
- N-glycosylation impacts various platelet functions, including adhesion, aggregation, and signaling.
- Defects in platelet N-glycosylation can contribute to the hemostatic abnormalities observed in CDG patients.
Conclusions:
- Platelets play a significant role in the clinical manifestations of CDG.
- Further investigation into platelet N-glycosylation is essential for understanding and potentially treating CDG.
Related Concept Videos
01:18Structure and Function of Platelets
2.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.6K
01:05Proteoglycans
4.5K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.5K
01:22Formation of the Platelet Plug
8.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.3K
01:24Disorders of Hemostasis
1.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K
01:29Protein Folding Quality Check in the RER
4.9K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
4.9K
01:24Oligosaccharide Assembly
3.4K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.4K